Neural Regeneration Research ›› 2017, Vol. 12 ›› Issue (1): 72-74.doi: 10.4103/1673-5374.198986

Previous Articles     Next Articles

Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage

Mark R. Kelley1, Jill C. Fehrenbacher2   

  1. 1. Pediatric Oncology Research; Departments of Biochemistry & Molecular Biology and Pharmacology & Toxicology; HB Wells Center for Pediatric Research; Basic Science Research, Indiana University Simon Cancer Center, Indianapolis, IN, USA; 
    2. Department of Pharmacology and Toxicology; Stark Neuroscience Research Institute; Department of Anesthesiology, Indiana University School of Medicine, Indianapolis, IN, USA
  • Received:2016-12-22 Online:2017-01-15 Published:2017-01-15
  • Contact: Mark R. Kelley, Ph.D., mkelley@iu.edu.
  • Supported by:

    Financial support for this work was provided by the National Cancer Institute [CA122298 (MRK) and the National Institutes of Health, [R21NS091667 (MRK and JCF)]. Additional financial support was provided by, the Earl and Betty Herr Professor in Pediatric Oncology Research, Jeff Gordon Children’s Foundation and the Riley Children’s Foundation (MRK) and IU Simon Cancer Center Neurotoxicity Working Group (MRK and JCF).

PDF

540